PPMonitor checks laboratory air quality

Published: 12-Apr-2010
Design & Build HVAC Regulatory

Enables effective and flexible management of indoor air quality

PPM Technology’s wireless IAQ profile PPMonitor enables simple, effective and flexible management of the indoor air environment of a laboratory or cleanroom.

The PPMonitor, from the Caernarfon, Wales firm, can continuously detect, measure and record temperature, humidity, formaldehyde, nitrogen dioxide, carbon monoxide, carbon dioxide, sulphur dioxide, ozone, ammonia and TVOCs.

The device incorporates a variety of advanced gas sensor technologies to monitor the target gases including NDIR, PID and electrochemical sensors.

The wireless units communicate via the Zigbee wireless mesh network, which can be extended by adding repeater nodes or additional PPMonitor or Mini PPMonitor units. Each unit can be configured with unique sensor specifications if required, allowing complete monitoring of the cleanroom air environment.

PPMonitor Units can be wirelessly connected to a Building Management System, in which BMS software allows the entire wireless system to be managed from a single PC. The BMS can activate and control air conditioning and ventilation systems; it can also turn on/off heating and trigger building alarms, if required.

All recorded data is stored automatically with dedicated software, which enables the data to be viewed graphically and produces reports and statistical data. Analysis of the recorded data over time allows for more efficient management of resources and energy.

See more

You may also like

Regulatory

PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency

Read more
The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)

Trending Articles

  1. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  2. PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)
  3. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey
  4. Autolus Therapeutics' CAR-T therapy, Aucatzyl, bags FDA approval for ALL Aucatzyl (obecabtagene autoleucel) is the first CAR-T therapy to receive FDA approval with no risk evaluation mitigation strategy requirement
  5. EU GMP Annex 1 (August 2022): impact on cleaning and disinfection Cleaning and microbial contamination control are critical focus areas in the pharmaceutical and medical device industries. Robust cleaning and disinfection programmes are needed to meet the required cleanroom microbial grades, to prevent cross-contamination and the subsequent microbial spoilage of products

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Regulatory

PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency

The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)
Manufacturing

IMed supports K2 medical systems in their EU MDR transition

Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
Regulatory

Autolus Therapeutics' CAR-T therapy, Aucatzyl, bags FDA approval for ALL

Aucatzyl (obecabtagene autoleucel) is the first CAR-T therapy to receive FDA approval with no risk evaluation mitigation strategy requirement
Packaging

Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future

To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack
Regulatory

New Berry bottle complements preservative-free eye treatment dispensing

Easy-squeeze ophthalmic bottle designed for use with Aptar Pharma’s dispenser
Manufacturing

Domino makes it easier than ever for pharmaceutical manufacturers to explore individual dose serialisation

New enhancements to the K600G printing solution streamline integration and usability
Regulatory

Novartis obtains FDA approval for CML drug, Scemblix

The TKI's approval is an important step forward for oncology patients with newly diagnosed chronic myeloid leukaemia, and was based on the results of the Phase III ASC4FIRST trial
Subscribe now